Adjunctive Intra-arterial Tenecteplase Following Mechanical Thrombectomy (ALLY) II Trial (NCT06949228)
🩺 Plain-English Summary (8th-Grade Level)
The study objective is to evaluate the safety and efficacy of Intra arterial (IA) Tenecteplase (TNK) as an adjunctive therapy in acute ischemic stroke (AIS) patients with large vessel occlusions (LVO) in the anterior circulation of Internal Carotid Artery (ICA), Middle Cerebral Arteries (M1 and M2) who achieve a reperfusion grade of Modified Treatment in Cerebral Ischemia Scale (mTICI) 2b or higher post-mechanical thrombectomy using Food and Drug Administration (FDA) approved devices.
Who can join: Review the eligibility criteria below.
Location: ProMedica Toledo Hospital — Toledo, Ohio
Age range: 18 Years to 85 Years
🧪 Interventions in This Study
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (1 Sites)
- ProMedica Toledo Hospital — Toledo, Ohio
📞 Contact the Study Coordinator
Phone: (419) 291-8027
Email: Syed.Zaidi2@utoledo.edu
Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Ischemic Stroke
- OsciPulse D-dimer Pilot Trial — Philadelphia, Pennsylvania
- Memantine for Enhanced Stroke Recovery — Salt Lake City, Utah
- Sleep for Stroke Management and Recovery Trial — Birmingham, Alabama
- Left Atrial Appendage Exclusion for Prophylactic Stroke Reduction Trial — Huntsville, Alabama
- A Safety and Tolerability Study of Neural Stem Cells (NR1) in Subjects With Chronic Ischemic Subcortical Stroke (ISS) — Stanford, California
- VNS-REHAB At-Home - Post-Market Study for Using the Vivistim System® at Home — Chicago, Illinois
Explore by condition: All Ischemic Stroke clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Contact the study coordinator using the phone/email above.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.